Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study. - Thatcher N; Goldschmidt JH; Thomas M; Schenker M; Pan Z; Rodriguez LP; Breder V; Ostoros G; Hanes V (Clinical cancer research : an official journal of the American Association for Cancer Research, 2019)